Skip to content

Clinical trials

Glomerulosclerosis, Focal Segmental trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulosclerosis, Focal Segmental Clear all

100 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20021
20032
20042
20052
20061
20072
20087
20096
20102
20112
20131
20142
20154
20163
20171
20188
20197
20205
20214
202210
20238
20245
20255
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46
Recruiting30
Terminated10
Unknown status5
Active, not recruiting4
Withdrawn4
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)11
Northwell Health6
Travere Therapeutics, Inc.6
University of Michigan5
Goldfinch Bio, Inc.3
Vertex Pharmaceuticals Incorporated3
Amgen2
Assistance Publique - Hôpitaux de Paris2
Columbia University2
Dimerix Bioscience Pty Ltd2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulosclerosis, Focal Segmental100
Nephrosis, Lipoid42
Nephrotic Syndrome26
Proteinuria23
Glomerulonephritis, IGA17
Kidney Diseases17
Glomerulonephritis, Membranous15
Diabetic Nephropathies11
Renal Insufficiency, Chronic10
Glomerulonephritis6

Trials

Showing 51 to 75 of 100. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.